Skip to main content
Hashim Khan, MD, Cardiology, San Diego, CA, Desert Regional Medical Center

HashimAliKhanMDFACC

Cardiology San Diego, CA

Adult Congenital Heart Disease, Interventional Cardiology

Interventional Cardiologist

Dr. Khan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Khan's full profile

Already have an account?

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Interventional Cardiology, 2014 - 2015
  • Scripps Clinic/Scripps Green Hospital
    Scripps Clinic/Scripps Green HospitalFellowship, Cardiovascular Disease, 2010 - 2013
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2006 - 2009
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 2006
  • University of Illinois at Urbana-Champaign
    University of Illinois at Urbana-ChampaignB.S., Cell & Structural Biology, With honors, 1998 - 2002

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2010 - 2026
  • TX State Medical License
    TX State Medical License 2015 - 2023
  • IL State Medical License
    IL State Medical License 2006 - 2017

Awards, Honors, & Recognition

  • Ruben Gittes Fellow Research Award Scripps Clinic/Scripps Green Hospital, 2013
  • Fellowship Teaching Award Scripps Clinic/Scripps Green Hospital, 2011
  • Resident teaching award Northwestern University Feinberg School of Medicine, 2006

Publications & Presentations

PubMed

Journal Articles

  • Can Hospital Rounds With Pocket Ultrasound By Cardiologists Reduce Standard Echocardiography?  
    Khan H, Wineinger NE, Uddin P, Mehta HS, Rubenson DS, Topol EJ, The American Journal of Medicine, 1/1/2014
  • Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition A new promising treatment for Acute Heart Failure syndromes?  
    Khan H, Metra M, Blair JE, Vogel M, Harinstein M, Filippatos G, Sabbah H, Valentini G, Porchet H, Gheorghiade M, Heart failure Reviews, 1/1/2009

Professional Memberships

Other Languages

  • Hindi, Urdu

Hospital Affiliations